Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09MCN
|
||||
Former ID |
DNC012924
|
||||
Drug Name |
Haloxysterol D
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527846] | ||
Structure |
Download2D MOL |
||||
Formula |
C29H52O5
|
||||
Canonical SMILES |
CCC(CC(C(C)C1CCC2C1(CCC3C2CC(C4(C3(C(CC(C4)O)O)C)O)O)C)<br />O)C(C)C
|
||||
InChI |
1S/C29H52O5/c1-7-18(16(2)3)12-24(31)17(4)21-8-9-22-20-14-26(33)29(34)15-19(30)13-25(32)28(29,6)23(20)10-11-27(21,22)5/h16-26,30-34H,7-15H2,1-6H3/t17-,18+,19-,20?,21+,22?,23?,24+,25-,26+,27+,28-,29-/m0/s1
|
||||
InChIKey |
SENGWVUFOJLNFP-QDQFXZLYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [527846] | |
Acetylcholinesterase | Target Info | Inhibitor | [527846] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.